RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome

被引:0
作者
Savira, Feby [1 ,2 ]
Edgley, Amanda J. [3 ]
Jucker, Beat M. [4 ]
Willette, Robert N. [4 ]
Krum, Henry [2 ]
Kelly, Darren J. [3 ]
Kompa, Andrew R. [2 ,3 ]
Wang, Bing H. [1 ,2 ]
机构
[1] Baker Heart & Diabet Res Inst, Biomarker Discovery Lab, Melbourne, Vic, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic, Australia
[3] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia
[4] GlaxoSmithKline, Heart Failure Discovery Performance Unit, King Of Prussia, PA USA
基金
英国医学研究理事会;
关键词
HYPERTROPHY; FIBROSIS;
D O I
10.1016/j.ijcard.2020.09.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:260 / 260
页数:1
相关论文
共 9 条
[1]   Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction [J].
Bao, Ming-Wei ;
Cai, Zhongxiang ;
Zhang, Xiao-Jing ;
Li, Liangpeng ;
Liu, Xiaoxiong ;
Wan, Nian ;
Hu, Gangying ;
Wan, Fengwei ;
Zhang, Rui ;
Zhu, Xueyong ;
Xia, Hao ;
Li, Hongliang .
BASIC RESEARCH IN CARDIOLOGY, 2015, 110 (03)
[2]   Effects of Selonsertib in Patients with Diabetic Kidney Disease [J].
Chertow, Glenn M. ;
Pergola, Pablo E. ;
Chen, Fang ;
Kirby, Brian J. ;
Sundy, John S. ;
Patel, Uptal D. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (10) :1980-1990
[3]   Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway [J].
Deng, Ting ;
Wei, Zhenming ;
Gael, Akindavyi ;
Deng, Xiaofang ;
Liu, Yunfeng ;
Lai, Jun ;
Hang, Liwei ;
Yan, Quanneng ;
Fu, Qiang ;
Li, Zhiliang .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (06) :535-544
[4]   Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II - Induced cardiac hypertrophy and remodeling [J].
Izumiya, Y ;
Kim, S ;
Izumi, Y ;
Yoshida, K ;
Yoshiyama, M ;
Matsuzawa, A ;
Ichijo, H ;
Iwao, H .
CIRCULATION RESEARCH, 2003, 93 (09) :874-883
[5]   ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice [J].
Liu, Qinghang ;
Sargent, Michelle A. ;
York, Allen J. ;
Molkentin, Jeffery D. .
CIRCULATION RESEARCH, 2009, 105 (11) :1110-U140
[6]   The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial [J].
Loomba, Rohit ;
Lawitz, Eric ;
Mantry, Parvez S. ;
Jayakumar, Saumya ;
Caldwell, Stephen H. ;
Arnold, Hays ;
Diehl, Anna Mae ;
Djedjos, C. Stephen ;
Han, Ling ;
Myers, Robert P. ;
Subramanian, G. Mani ;
McHutchison, John G. ;
Goodman, Zachary D. ;
Afdhal, Nezam H. ;
Charlton, Michael R. .
HEPATOLOGY, 2018, 67 (02) :549-559
[7]   Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome [J].
Savira, Feby ;
Wang, Bing H. ;
Edgley, Amanda J. ;
Jucker, Beat M. ;
Willette, Robert N. ;
Krum, Henry ;
Kelly, Darren J. ;
Kompa, Andrew R. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 310 :128-136
[8]   Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy [J].
Taniike, Masayuki ;
Yamaguchi, Osamu ;
Tsujimoto, Ikuko ;
Hikoso, Shungo ;
Takeda, Toshihiro ;
Nakai, Atsuko ;
Omiya, Shigemiki ;
Mizote, Isamu ;
Nakano, Yuko ;
Higuchi, Yoshiharu ;
Matsumura, Yasushi ;
Nishida, Kazuhiko ;
Ichijo, Hidenori ;
Hori, Masatsugu ;
Otsu, Kinya .
CIRCULATION, 2008, 117 (04) :545-552
[9]  
Yang W., 2017, HEART LUNG CIRC, VS1443-9506, P31522